Anabel Franco‐Moreno

767 total citations
48 papers, 276 citations indexed

About

Anabel Franco‐Moreno is a scholar working on Internal Medicine, Infectious Diseases and Neurology. According to data from OpenAlex, Anabel Franco‐Moreno has authored 48 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 18 papers in Infectious Diseases and 15 papers in Neurology. Recurrent topics in Anabel Franco‐Moreno's work include Venous Thromboembolism Diagnosis and Management (23 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (12 papers). Anabel Franco‐Moreno is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), COVID-19 Clinical Research Studies (16 papers) and Long-Term Effects of COVID-19 (12 papers). Anabel Franco‐Moreno collaborates with scholars based in Spain, Denmark and Italy. Anabel Franco‐Moreno's co-authors include Juan Torres‐Macho, Nuria Muñoz‐Rivas, César Fernández‐de‐las‐Peñas, B. Mestre-Gómez, A. Zapatero Gaviría, José Manuel Ruiz‐Giardín, Jacqueline Veronica Velasco, Kin Israel Notarte, Pablo Ryan and Giuseppe Lippi and has published in prestigious journals such as The Journals of Gerontology Series A, Journal of Medical Virology and Health and Quality of Life Outcomes.

In The Last Decade

Anabel Franco‐Moreno

39 papers receiving 272 citations

Peers

Anabel Franco‐Moreno
Rehan Saeed United States
F. Chagué France
Naveen Dhawan United States
Anjali Rao United States
Divyansh Sharma Australia
Osama Mukhtar United States
Rehan Saeed United States
Anabel Franco‐Moreno
Citations per year, relative to Anabel Franco‐Moreno Anabel Franco‐Moreno (= 1×) peers Rehan Saeed

Countries citing papers authored by Anabel Franco‐Moreno

Since Specialization
Citations

This map shows the geographic impact of Anabel Franco‐Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anabel Franco‐Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anabel Franco‐Moreno more than expected).

Fields of papers citing papers by Anabel Franco‐Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anabel Franco‐Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anabel Franco‐Moreno. The network helps show where Anabel Franco‐Moreno may publish in the future.

Co-authorship network of co-authors of Anabel Franco‐Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Anabel Franco‐Moreno. A scholar is included among the top collaborators of Anabel Franco‐Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anabel Franco‐Moreno. Anabel Franco‐Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franco‐Moreno, Anabel, et al.. (2025). Riesgo de tromboembolia venosa en población transgénero en terapia hormonal: una revisión sistemática y metaanálisis. Medicina Clínica. 164(12). 106921–106921. 1 indexed citations
3.
Franco‐Moreno, Anabel, et al.. (2024). External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study. Clinical & Translational Oncology. 26(10). 2685–2692. 3 indexed citations
4.
Fernández‐de‐las‐Peñas, César, Juan Torres‐Macho, Jesus Alfonso Catahay, et al.. (2024). Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 52(5). 1687–1687. 1 indexed citations
5.
Fernández‐de‐las‐Peñas, César, Juan Torres‐Macho, María Ruiz‐Ruigómez, et al.. (2024). Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study. Journal of Medical Virology. 96(5). e29676–e29676. 5 indexed citations
6.
Fernández‐de‐las‐Peñas, César, Gema Dı́az-Gil, Silvia Ambite‐Quesada, et al.. (2024). Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors. Viruses. 16(2). 275–275. 3 indexed citations
7.
Fernández‐de‐las‐Peñas, César, Gema Dı́az-Gil, Silvia Ambite‐Quesada, et al.. (2024). DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19. Microorganisms. 12(7). 1304–1304.
9.
Franco‐Moreno, Anabel, et al.. (2023). Prediction of Venous Thromboembolism in Patients With Cancer Using Machine Learning Approaches: A Systematic Review and Meta-Analysis. JCO Clinical Cancer Informatics. 7(7). e2300060–e2300060. 9 indexed citations
10.
Fernández‐de‐las‐Peñas, César, Carlos Guijarro, Juan Torres‐Macho, et al.. (2023). Serological Biomarkers at Hospital Admission and Hospitalization Treatments Are Not Related to Sensitization-Associated Symptoms in Patients with Post-COVID Pain. Pathogens. 12(10). 1235–1235. 1 indexed citations
11.
Franco‐Moreno, Anabel, et al.. (2023). Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection. Journal of Clinical and Translational Research. 9(2). 59–68. 1 indexed citations
12.
Franco‐Moreno, Anabel, et al.. (2022). Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review. Revista Clínica Española (English Edition). 223(1). 40–49. 4 indexed citations
13.
Esteve, María, et al.. (2020). El hospital como centro promotor de espacios sin humo: Estrategias dirigidas al control del tabaquismo. Revista Española de Salud Pública. 94(94). 35.
14.
Franco‐Moreno, Anabel, et al.. (2018). Application of Telemedicine for the Control of Patients with Acute and Chronic Heart Diseases. Telemedicine Journal and e-Health. 25(11). 1033–1039. 12 indexed citations
15.
Cabezón‐Gutiérrez, Luis, et al.. (2018). Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib. Cureus. 10(7). e2982–e2982. 1 indexed citations
16.
Franco‐Moreno, Anabel, et al.. (2017). Anticoagulantes orales directos: puesta al día. Medicina Clínica. 151(5). 198–206. 29 indexed citations
17.
Franco‐Moreno, Anabel, et al.. (2016). Riesgo de recurrencia en el tromboembolismo venoso idiopático. Revista Clínica Española. 216(9). 488–494. 2 indexed citations
18.
Cabezón‐Gutiérrez, Luis, et al.. (2015). Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature. World Journal of Oncology. 6(6). 485–490. 2 indexed citations
19.
Farfán‐Sedano, Ana Isabel, et al.. (2012). Place of residence before hospital admission and mortality at 12‐months in Spanish patients aged 70 years or older. Geriatrics and gerontology international. 12(4). 695–702. 3 indexed citations
20.
Franco‐Moreno, Anabel, et al.. (2003). Estudio sobre la prevalencia del burnout en los médicos del Área Sanitaria de Talavera de la Reina. Atención Primaria. 32(6). 343–348. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026